MicroRNA-27b alleviates septic cardiomyopathy by targeting the Mff/MAVS axis

Xincai Wang1, Long Huang1, Jingqing Xu1

  • 1Department of Critical Care Medicine, Shengli Clinical Medical College of Fujian Medical University, Fuzhou University Affiliated Provincial Hospital, Fujian Provincial Hospital, Fujian Provincial Center for Critical Care Medicine, Fujian Provincial Key Laboratory of Critical Care Medicine, Fuzhou, China.

Abstract

Insights

MicroRNA-27b (miR-27b) protects against septic cardiomyopathy (SCM) by targeting the Mff/MAVS pathway. This finding highlights miR-27b as a potential therapeutic target for SCM.

Area of Science:

  • Cardiovascular Biology
  • Molecular Medicine
  • Mitochondrial Biology

Background:

  • Septic cardiomyopathy (SCM) is a severe complication of sepsis, characterized by cardiac dysfunction and myocardial injury.
  • Mitochondrial dysfunction plays a critical role in the pathogenesis of SCM.
  • The role of microRNAs in regulating mitochondrial dynamics and inflammation in SCM remains incompletely understood.

Purpose of the Study:

  • To investigate the protective role of microRNA-27b (miR-27b) in septic cardiomyopathy (SCM).
  • To elucidate the regulatory mechanism of miR-27b on the mitochondrial fission factor (Mff)/mitochondrial antiviral signaling protein (MAVS) axis in SCM.

Main Methods:

  • Analysis of transcriptome data from septic patient cardiac tissues (GSE79962).
  • Measurement of serum miR-27b levels in SCM patients, sepsis patients, and healthy controls.
  • Establishment of mouse SCM and HL-1 cardiomyocyte models induced by lipopolysaccharide (LPS).
  • Investigation of molecular mechanisms using miR-27b modulators and Mff intervention, coupled with RT-qPCR, Western blot, immunofluorescence, and electron microscopy.

Main Results:

  • Downregulation of miR-27b was observed in SCM cardiac tissues and serum.
  • LPS-induced SCM models exhibited cardiac dysfunction, myocardial injury, and mitochondrial abnormalities.
  • miR-27b targeted Mff, maintaining mitochondrial homeostasis and attenuating LPS-induced inflammation and apoptosis; Mff overexpression reversed these effects.

Conclusions:

  • miR-27b alleviates myocardial injury and inflammation in SCM by targeting the Mff/MAVS axis.
  • Maintaining mitochondrial homeostasis via miR-27b offers a potential therapeutic strategy for SCM.
  • miR-27b represents a promising novel therapeutic target for SCM.

Related Concept Videos

Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
31
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
48
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
22
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.7K
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
34